Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates.
Abdelaziz HM, Gaber M, Abd-Elwakil MM, Mabrouk MT, Elgohary MM, Kamel NM, Kabary DM, Freag MS, Samaha MW, Mortada SM, Elkhodairy KA, Fang JY, Elzoghby AO.
Abdelaziz HM, et al. Among authors: elzoghby ao.
J Control Release. 2018 Jan 10;269:374-392. doi: 10.1016/j.jconrel.2017.11.036. Epub 2017 Nov 24.
J Control Release. 2018.
PMID: 29180168
Review.